Molecular basis of interferon-gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components

J Biol Chem. 1990 Nov 25;265(33):20241-6.

Abstract

In this study, we analyzed the expression of genes encoding for components of the phagocyte superoxide anion-generating system in human phagocytes treated with interferon-gamma (IFN-gamma) or lipopolysaccharide (LPS). Human neutrophils express high levels of the 47-kDa cytosolic factor (p47-phox), which are down-regulated after treatment with IFN-gamma, but not with LPS. On the contrary, the steady-state levels of the heavy chain subunit of cytochrome b558 (gp91-phox) were increased by IFN-gamma and LPS in human monocyte-derived macrophages and neutrophils in a time- and dose-dependent fashion, whereas cytochrome b558 light chain subunit (p22-phox) mRNA was not influenced by either agent. Studies on post-transcriptional regulation at the level of mRNA stability indicate that, in neutrophils, IFN-gamma has no influence on gp91-phox and p47-phox mRNA half-lives. The content of the two cytochrome b558 subunits was quantified by enzyme-linked immunosorbent assay, which revealed that, in neutrophils, gp91-phox levels doubled after 4 h of treatment with IFN-gamma or LPS. Monocyte/macrophage maturation was associated with a gradual decrease in gp91-phox mRNA and protein levels, which were both restored by treatment with IFN-gamma for 24-48 h. These results suggest that induction of the gp91-phox gene and protein product by IFN-gamma or LPS is an important requirement in the mechanism of the enhancement of neutrophil and macrophage oxidative metabolism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cells, Cultured
  • Cytochrome b Group / blood
  • Cytochrome b Group / genetics
  • Enzyme-Linked Immunosorbent Assay
  • Gene Expression / drug effects*
  • Humans
  • Interferon-gamma / pharmacology*
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / enzymology
  • Leukocytes, Mononuclear / physiology*
  • Lipopolysaccharides / pharmacology*
  • Macromolecular Substances
  • Macrophages / drug effects
  • Macrophages / enzymology
  • Macrophages / physiology
  • NADH, NADPH Oxidoreductases / blood
  • NADH, NADPH Oxidoreductases / genetics*
  • NADPH Oxidases
  • Neutrophils / drug effects
  • Neutrophils / enzymology
  • Neutrophils / physiology*
  • RNA, Messenger / drug effects
  • RNA, Messenger / genetics
  • Recombinant Proteins
  • Superoxides / blood*

Substances

  • Cytochrome b Group
  • Lipopolysaccharides
  • Macromolecular Substances
  • RNA, Messenger
  • Recombinant Proteins
  • Superoxides
  • Interferon-gamma
  • cytochrome b558
  • NADH, NADPH Oxidoreductases
  • NADPH Oxidases